PharmaCyte BiotechPMCB 
$1.53-2.55%24h
-2.55%24h
Global rank31881
Market cap$29.82M
Change 7d-22.34%
YTD Performance-30.45%
SP500 benchmarkUnderperform
P/E-6.95
P/S0
Revenue$0
Earnings-$4.32M
Dividend yield-
Main Sector
Healthcare
EPS for PharmaCyte Biotech (PMCB)
PharmaCyte Biotech has an EPS of $-0.22. In 2022, the company made an earnings per share (EPS) of $-0.27. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for PMCB
-
Value:-
EPS history for PharmaCyte Biotech from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.22 | -18.52% |
| 2022 | -$0.27 | -88.98% |
| 2021 | -$2.45 | -42.07% |
| 2020 | -$4.23 | - |
View the highest EPS stocks
